[Adjuvant treatment with trastuzumab in early breast cancer].


The introduction of new biological agents into the clinic has had a major impact on breast cancer care. Of all well-studied biological agents, Trastuzumab is the only one that has become part of the standard therapy for advanced as well as for early breast cancer. Dr. Tahover and her colleagues' review in this issue of "Harefuah" presents the pivotal trials… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics